- Home
- CRDF vs VBF Comparison
CRDF vs VBF Comparison
Compare CRDF & VBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- VBF
- Stock Information
- Founded
- CRDF 1999
- VBF 1970
- Country
- CRDF United States
- VBF United States
- Employees
- CRDF N/A
- VBF N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- VBF Trusts Except Educational Religious and Charitable
- Sector
- CRDF Health Care
- VBF Finance
- Exchange
- CRDF Nasdaq
- VBF Nasdaq
- Market Cap
- CRDF 152.3M
- VBF 179.5M
- IPO Year
- CRDF N/A
- VBF N/A
- Fundamental
- Price
- CRDF $2.15
- VBF $15.52
- Analyst Decision
- CRDF Strong Buy
- VBF
- Analyst Count
- CRDF 4
- VBF 0
- Target Price
- CRDF $10.63
- VBF N/A
- AVG Volume (30 Days)
- CRDF 723.0K
- VBF 45.5K
- Earning Date
- CRDF 11-06-2025
- VBF 01-01-0001
- Dividend Yield
- CRDF N/A
- VBF 5.18%
- EPS Growth
- CRDF N/A
- VBF N/A
- EPS
- CRDF N/A
- VBF N/A
- Revenue
- CRDF $501,000.00
- VBF N/A
- Revenue This Year
- CRDF N/A
- VBF N/A
- Revenue Next Year
- CRDF N/A
- VBF N/A
- P/E Ratio
- CRDF N/A
- VBF N/A
- Revenue Growth
- CRDF N/A
- VBF N/A
- 52 Week Low
- CRDF $1.90
- VBF $13.68
- 52 Week High
- CRDF $5.64
- VBF $16.27
- Technical
- Relative Strength Index (RSI)
- CRDF 43.50
- VBF 46.09
- Support Level
- CRDF $2.06
- VBF $15.52
- Resistance Level
- CRDF $2.33
- VBF $15.83
- Average True Range (ATR)
- CRDF 0.11
- VBF 0.15
- MACD
- CRDF -0.01
- VBF -0.01
- Stochastic Oscillator
- CRDF 25.00
- VBF 32.35
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About VBF Invesco Bond Fund
Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.